Agomab Therapeutics NV

AGMBNASDAQ · US

Holders

ACQUIREDT+2
Epstein David R
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $44.5K
Filed 9 Oct 2026SEC Form 4view source
ACQUIREDT+7
Epstein David R
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $43.5K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Knotnerus Tim Jasper
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $43.5K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Kemula Pierre Thadee Victor
Agomab Therapeutics NV · NASDAQ
+2,000 sh · $17.1K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Epstein David R
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $42.9K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Kemula Pierre Thadee Victor
Agomab Therapeutics NV · NASDAQ
+5,000 sh · $42.9K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Kemula Pierre Thadee Victor
Agomab Therapeutics NV · NASDAQ
+3,000 sh · $26.0K
Filed 7 Oct 2026SEC Form 4view source
ACQUIREDT+7
Knotnerus Tim Jasper
Agomab Therapeutics NV · NASDAQ
+6,000 sh · $50.9K
Filed 7 Oct 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Agomab Therapeutics NV · NASDAQ
14,241 sh · $149.4K
Filed 31 Mar 2026SEC 13Fview source